More articles from IMMUNOPHARMACOLOGY

You have access
FK-506 and Cyclosporin A Potentiate the IgE Antibody Production by Contact Sensitization with Hapten in Mice
Hiroichi Nagai, Hidetaka Hiyama, Akihiko Matsuo, Yoshifumi Ueda, Naoki Inagaki and Kenji Kawada

Journal of Pharmacology and Experimental Therapeutics October 1997, 283 (1) 321-327;
You have access
BMS-190394, a Selectin Inhibitor, Prevents Rat Cutaneous Inflammatory Reactions
Gordon Todderud, Xina Nair, Debbie Lee, Julie Alford, Lynda Davern, Paul Stanley, Carol Bachand, Philippe Lapointe, Anne Marinier, Alain Martel, Marcel Menard, John J. Wright, Jurgen Bajorath, Diane Hollenbaugh, Alejandro Aruffo and Kenneth M. Tramposch

Journal of Pharmacology and Experimental Therapeutics September 1997, 282 (3) 1298-1304;
You have access
Patients with Delayed-Onset Sulfonamide Hypersensitivity Reactions Have Antibodies Recognizing Endoplasmic Reticulum Luminal Proteins
Alastair E. Cribb, Lance R. Pohl, Stephen P. Spielberg and J. Steven Leeder

Journal of Pharmacology and Experimental Therapeutics August 1997, 282 (2) 1064-1072;
You have access
Ethodin: Pharmacological Evidence of the Interaction between Smooth Muscle and Mast Cells in the Myometrium
María Isolde Rudolph, Maria de los Angeles García, Marcia Sepulveda, Enrique Brandan, Karin Reinicke, Sandra Nicovani and Leonor Villan

Journal of Pharmacology and Experimental Therapeutics July 1997, 282 (1) 256-261;
You have access
MK-801 Limits Neurovascular Dysfunction during Experimental Allergic Encephalomyelitis
Christopher Bolton and Carolyn Paul

Journal of Pharmacology and Experimental Therapeutics July 1997, 282 (1) 397-402;
You have access
The Natural Product Hymenialdisine Inhibits Interleukin-8 Production in U937 Cells by Inhibition of Nuclear Factor-κB
John J. Breton and Marie C. Chabot-Fletcher

Journal of Pharmacology and Experimental Therapeutics July 1997, 282 (1) 459-466;
You have access
Differential Regulation of Human Antigen-Specific Th1 and Th2 Lymphocyte Responses by Isozyme Selective Cyclic Nucleotide Phosphodiesterase Inhibitors
David M. Essayan, Anne Kagey-Sobotka, Lawrence M. Lichtenstein and Shau-Ku Huang

Journal of Pharmacology and Experimental Therapeutics July 1997, 282 (1) 505-512;
You have access
Losartan, a Selective Inhibitor of Subtype AT1 Receptors for Angiotensin II, Inhibits the Binding ofN-Formylmethionyl-leucyl-phenylalanine to Neutrophil Receptors
Silvina Raiden, Mirta Giordano, Graciela Andonegui, Analía S. Trevani, Daniel H. López, Victor Nahmod and Jorge R. Geffner

Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 624-628;
You have access
Cysteinyl Leukotrienes Induce P-Selectin Expression in Human Endothelial Cells via a Non-CysLT₁ Receptor-Mediated Mechanism
Karen E. Pedersen, Bruce S. Bochner and Bradley J. Undem

Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 655-662;
You have access
A Peptidomimetic that Specifically Inhibits Human Leukocyte Antigen DRB1^*0401-restricted T Cell Proliferation
Susan L. Woulfe, Christine P. Bono, Michelle L. Zacheis, Joseph K. Welply, Dawn A. Kirschmann, Troy A. Baudino, Yang Wang, Deborah A. Stone, Gunnar J. Hanson, Jennifer L. Vuletich, Louis J. Bedell, Benjamin D. Schwartz and Susan C. Howard

Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 663-669;

Main menu

User menu

Search

More articles from IMMUNOPHARMACOLOGY

Pages

Navigate

More Information

ASPET's Other Journals